Luteal Phase and Symptom-Onset Dosing of SSRIs/SNRIs in the Treatment of Premenstrual Dysphoria: Clinical Evidence and Rationale Meir SteinerTina Li Leading Article 01 June 2013 Pages: 583 - 589
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis Jiwon OhPaul W. O’Connor Review Article 26 June 2013 Pages: 591 - 609
Causes of CNS Inflammation and Potential Targets for Anticonvulsants Mercé FalipXavier Salas-PuigCarlos Cara Review Article 15 June 2013 Pages: 611 - 623
The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in Schizophrenia A. George AwadLakshmi N. P. Voruganti Review Article 12 June 2013 Pages: 625 - 636
Long-Acting Injectable Formulations of New-Generation Antipsychotics: A Review from a Clinical Perspective Anna-Sophia RauchW. Wolfgang Fleischhacker Review Article 19 June 2013 Pages: 637 - 652
Buprenorphine Use in Pregnant Opioid Users: A Critical Review Michael Soyka Review Article 18 June 2013 Pages: 653 - 662
Effect of Tolcapone on Brain Activity During a Variable Attentional Control Task: A Double-Blind, Placebo-Controlled, Counter-Balanced Trial in Healthy Volunteers Sophia C. MagalonaRoberta RasettiVenkata S. Mattay Original Research Article 21 June 2013 Pages: 663 - 673
Erratum to: Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence Jerome SarrisErica McIntyreDavid A. Camfield Erratum 26 June 2013 Pages: 675 - 675
Erratum to: Rediscovering Trazodone for the Treatment of Major Depressive Disorder Andrea FagioliniAlessandro ComandiniSiegfried Kasper Erratum 02 July 2013 Pages: 677 - 677
